Literature DB >> 11823587

The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful.

M Emília Juan1, M Pilar Vinardell, Joana M Planas.   

Abstract

trans-3,5,4'-Trihydroxystilbene (trans-resveratrol) is a phytochemical present in peanuts, grapes and wine with beneficial effects such as protection against cardiovascular disease and cancer prevention. The purpose of this study was to evaluate whether high doses of trans-resveratrol have harmful effects on Sprague-Dawley rats. trans-Resveratrol was administered orally to male rats for 28 d at a dose of 20 mg/(kg x d), 1000 times the amount consumed by a 70-kg person taking 1.4 g of trans-resveratrol/d. Body weight, and food and water consumption did not differ between rats treated with trans-resveratrol and the control group. Hematologic and biochemical variables were not affected by the treatment. Histopathologic examination of the organs obtained at autopsy did not reveal any alterations. These results support the view that repeated consumption of trans-resveratrol at 20 mg/(kg x d) does not adversely affect the variables tested in rats.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11823587     DOI: 10.1093/jn/132.2.257

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  69 in total

1.  Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity.

Authors:  W D Johnson; R L Morrissey; A L Usborne; I Kapetanovic; J A Crowell; M Muzzio; D L McCormick
Journal:  Food Chem Toxicol       Date:  2011-09-10       Impact factor: 6.023

2.  Trans-resveratrol oral administration does not affect the enzymatic activities in rat small intestine.

Authors:  M E Juan; J M Planas
Journal:  J Physiol Biochem       Date:  2002-03       Impact factor: 4.158

Review 3.  Berries: improving human health and healthy aging, and promoting quality life--a review.

Authors:  Octavio Paredes-López; Martha L Cervantes-Ceja; Mónica Vigna-Pérez; Talía Hernández-Pérez
Journal:  Plant Foods Hum Nutr       Date:  2010-09       Impact factor: 3.921

4.  Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer.

Authors:  Matthew Truong; Mackenzie R Cook; Scott N Pinchot; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Ann Surg Oncol       Date:  2010-12-24       Impact factor: 5.344

5.  Oncogenicity evaluation of resveratrol in p53(+/-) (p53 knockout) mice.

Authors:  T L Horn; M J Cwik; R L Morrissey; I Kapetanovic; J A Crowell; T D Booth; D L McCormick
Journal:  Food Chem Toxicol       Date:  2006-08-08       Impact factor: 6.023

6.  In vitro effects of resveratrol on Trichinella spiralis.

Authors:  Soykan Ozkoc; Sema Tuncay; Songul Bayram Delibas; Ciler Akisu
Journal:  Parasitol Res       Date:  2009-06-28       Impact factor: 2.289

7.  In vitro antileishmanial activity of resveratrol and its hydroxylated analogues against Leishmania major promastigotes and amastigotes.

Authors:  Lukasz Kedzierski; Joan M Curtis; Milena Kaminska; Jadwiga Jodynis-Liebert; Marek Murias
Journal:  Parasitol Res       Date:  2007-09-01       Impact factor: 2.289

8.  Effect of resveratrol and environmental enrichment on biomarkers of oxidative stress in young healthy mice.

Authors:  Mustapha Shehu Muhammad; Rabiu Abdussalam Magaji; Aliyu Mohammed; Ahmed-Sherif Isa; Mohammed Garba Magaji
Journal:  Metab Brain Dis       Date:  2016-08-15       Impact factor: 3.584

9.  Endoplasmic reticulum stress-induced cell death in dopaminergic cells: effect of resveratrol.

Authors:  Shankar J Chinta; Karen S Poksay; Gaayatri Kaundinya; Matthew Hart; Dale E Bredesen; Julie K Andersen; Rammohan V Rao
Journal:  J Mol Neurosci       Date:  2009-01-15       Impact factor: 3.444

10.  Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats.

Authors:  Manar Hamed Arafa; Nanies Sameeh Mohammad; Hebatallah Husseini Atteia; Hesham Radwan Abd-Elaziz
Journal:  J Physiol Biochem       Date:  2014-06-18       Impact factor: 4.158

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.